Our History

Growing to Support a Healthier Nation with Homegrown Healthcare Solutions

Duopharma Biotech has expanded over the decades to support local healthcare alongside Malaysia’s development.

The Company’s formal history began with the establishment of Duopharma (M) Sendirian Berhad in 1978 and the incorporation of Duopharma Biotech in 2000. Today, as a leading publicly-traded Malaysian pharmaceutical company, Duopharma Biotech focuses on growing its portfolio in the Manufacturing, Research & Development and Commercialisation & Marketing of generic drugs and biosimilars, to deliver high quality, innovative and accessible solutions across Malaysia and the world over.

1978

Establishment of Duopharma (M) Sendirian Berhad as a trading company

2002

Listed on Bursa Malaysia

2005

Chemical Company of Malaysia Berhad (CCMB) acquired Duopharma Biotech Berhad

2006

Duopharma Biotech Berhad rebranded as CCM Duopharma Biotech Berhad (CCMD)

2015

Restructuring of pharmaceutical companies under CCMD

2017

Demerger of CCMD from CCMB

2019

CCMD changed its name to Duopharma Biotech Berhad

2020

Commercialisation of selected speciality products at HAPI Plant

2021

Participated in the national vaccination programme on the provision of Covid-19 vaccines

2022

Received first Halal-Certified Cancer Treatment

2023

Establishment of PT Duopharma Healthcare Indonesia, a wholly-owned subsidiary of Duopharma Biotech Berhad